PRESS RELEASE published on 09/07/2023 at 08:00, 2 years 6 months ago Abivax fait un point d’avancement sur son activité opérationnelle et commerciale
PRESS RELEASE published on 08/31/2023 at 18:00, 2 years 6 months ago ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.07.23
PRESS RELEASE published on 08/23/2023 at 18:00, 2 years 6 months ago Abivax appoints Patrick Malloy as Senior Vice President Investor Relations
PRESS RELEASE published on 08/23/2023 at 18:00, 2 years 6 months ago ABIVAX: Patrick Malloy est nommé Senior Vice-Président Relations Investisseurs d’Abivax
PRESS RELEASE published on 08/21/2023 at 08:00, 2 years 7 months ago Abivax obtient un financement maximum de 150 millions d’euros dans le cadre de deux operations de financements structures
PRESS RELEASE published on 08/21/2023 at 08:00, 2 years 7 months ago Abivax secures up to EUR 150M from two structured debt financing transactions
PRESS RELEASE published on 08/10/2023 at 18:00, 2 years 7 months ago Abivax announces plans to conduct registered public offering in the United States
PRESS RELEASE published on 08/10/2023 at 18:00, 2 years 7 months ago Abivax annonce son intention de proceder a une offre au public aux Etats-Unis
PRESS RELEASE published on 08/02/2023 at 18:00, 2 years 7 months ago ABIVAX: NOTICE TO HOLDERS OF BONDS CONVERTIBLE AND/OR EXCHANGEABLE INTO NEW AND/OR EXISTING SHARES (OCEANE) WITH A NOMINAL VALUE OF EUR 24,999,975.99
PRESS RELEASE published on 08/02/2023 at 18:00, 2 years 7 months ago ABIVAX: AVIS AUX PORTEURS D’OBLIGATIONS CONVERTIBLES/ECHANGEABLES EN ACTIONS NOUVELLES ET/OU EXISTANTES (OCEANES) D’UN MONTANT NOMINAL DE 24 999 975,99 EUROS
Published on 03/23/2026 at 08:00, 2 hours 16 minutes ago ABRIDGED, PRELIMINARY AND UNAUDITED QUARTERLY AND FULL YEAR RESULTS AND DETAILS OF MANAGEMENT CONFERENCE Call for the Fourth Quarter and Full Year Ended December 31, 2025 ("The Quarter" or "Q4 2025" and "FY 2025" Respectively)
Published on 03/23/2026 at 02:00, 8 hours 16 minutes ago FutureGen Industries Announces Open Market Investments
Published on 03/23/2026 at 09:19, 57 minutes ago Mister Spex Chooses Salesforce to further develop its Omnichannel Strategy
Published on 03/23/2026 at 09:00, 1 hour 16 minutes ago EQS Group launches Risk Management module to support continuous data and AI risk oversight
Published on 03/23/2026 at 08:10, 2 hours 6 minutes ago Entrée en négociations exclusives de cession de la participation dans Winncare
Published on 03/20/2026 at 19:00, 2 days 15 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 15 hours ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 16 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 16 hours ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
